epVIR ApS: Financial statements 2022
CVR: 39457679
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
epVIR ApS (CVR 39457679) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1 and a net result of DKK 1 compared with DKK -19 the year before. Equity in the 2022 report amounted to DKK 4,035. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 1
- Profit/Loss
- DKK 1
- Equity
- DKK 4,035
- Total Assets
- DKK 4,035
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 1 | 1 | 4 t. | 0 |
| 2021 | 0 | -24 | -19 | 4 t. | 0 |
| 2020 | 0 | -24 | -19 | 4 t. | 0 |
| 2019 | - | -38 t. | -38 t. | 4 t. | 0 |
Keep an eye on epVIR ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
EpVIR ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -19.
About epVIR ApS
epVIR ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company has been dissolved on 19 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2022 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK 1 and a net result of DKK 1 compared with DKK -19 the year before. Equity in the 2022 report amounted to DKK 4,035.